Medication info
Zitramex XL Extended-release Tablet 150mg (Tramadol Hydrochloride)

Zitramex XL Extended-release Tablet 150mg (Tramadol Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›150mg / 1 tablet
Manufacturer / importer
Mundipharma Korea Ltd
Appearance
White film-coated oblong extended-release tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 199806740 · Approved 1998.12.05 · Insurance code 678000140

Summary

Main use
Relief of moderate·severe acute·chronic pain (e.g., cancer pain) and pain after diagnostic procedures·surgery
Who takes it
Adults · Children
Adult dose
The dose of this drug should be adjusted according to the patient's pain intensity and clinical response. In general, use the lowest dose that relieves pain. The appropriate dose for each patient is the amount that controls pain over 24 hours without adverse effects or with only mild, tolerable adverse effects. Unless there are special clinical circumstances, do not exceed 400mg of tramadol hydrochloride per day. This drug should be administered at 24-hour intervals and swallowed whole without chewing. To minimize transient adverse effects, it is advisable to increase the dose gradually. Since withdrawal symptoms or drug dependence have been reported, patients requiring continuous administration should be evaluated regularly. When switching a patient receiving regular tramadol hydrochloride preparations to this drug, calculate the total daily dose and start with the dose closest to the dose range of this drug. No dose adjustment is required in patients 75 years or younger without clinically identified hepatic or renal impairment. In patients over 75 years, elimination of this drug may be delayed; adjust the dosing interval if necessary. In patients over 75 years and in patients with renal or hepatic impairment, elimination of this drug may be delayed; consider extending the dosing interval in these patients. Start with an initial dose of 150mg of tramadol hydrochloride once daily, and monitor closely when adjusting the dose. Do not use in patients with severe renal impairment (creatinine clearance < 10 ml/min).
Child dose
Children aged 12 years or older: Usually administer 150mg of tramadol hydrochloride once daily. If adequate analgesia is not achieved, increase the dose until analgesia is achieved.

Ingredients

Importer
Mundipharma Korea Ltd

Efficacy & effects

Relief of moderate·severe acute·chronic pain (e.g., cancer pain) and pain after diagnostic procedures·surgery

  • Severe pain
  • moderate pain
  • acute pain
  • chronic pain
  • various cancer pain
  • post-diagnostic pain
  • post-surgical pain
View approved original text

This medication is used to alleviate severe and moderate acute and chronic pain, such as pain associated with various cancers, as well as pain that occurs after diagnosis or surgery.

How to take

Adult dose

The dose of this drug should be adjusted according to the patient's pain intensity and clinical response. In general, use the lowest dose that relieves pain. The appropriate dose for each patient is the amount that controls pain over 24 hours without adverse effects or with only mild, tolerable adverse effects. Unless there are special clinical circumstances, do not exceed 400mg of tramadol hydrochloride per day. This drug should be administered at 24-hour intervals and swallowed whole without chewing. To minimize transient adverse effects, it is advisable to increase the dose gradually. Since withdrawal symptoms or drug dependence have been reported, patients requiring continuous administration should be evaluated regularly. When switching a patient receiving regular tramadol hydrochloride preparations to this drug, calculate the total daily dose and start with the dose closest to the dose range of this drug. No dose adjustment is required in patients 75 years or younger without clinically identified hepatic or renal impairment. In patients over 75 years, elimination of this drug may be delayed; adjust the dosing interval if necessary. In patients over 75 years and in patients with renal or hepatic impairment, elimination of this drug may be delayed; consider extending the dosing interval in these patients. Start with an initial dose of 150mg of tramadol hydrochloride once daily, and monitor closely when adjusting the dose. Do not use in patients with severe renal impairment (creatinine clearance < 10 ml/min).

Child dose

Children aged 12 years or older: Usually administer 150mg of tramadol hydrochloride once daily. If adequate analgesia is not achieved, increase the dose until analgesia is achieved.

Precautions

This medication may cause seizures if taken in excess of the recommended dosage. Caution is advised, particularly for patients with epilepsy or those at risk of seizures; use of this medication should be limited to essential cases only. Prolonged use may lead to psychological and physical dependence, so patients with a history of drug abuse should use it for a short period under strict supervision. Co-administration with central nervous system depressants or alcohol can lead to severe sedation, respiratory depression, hypotension, or coma, so it is advisable not to use them together. Patients for whom the CYP2D6 enzyme acts very rapidly may experience excessive accumulation of the active ingredient in the body, increasing the risk of respiratory depression, necessitating dosage adjustments and careful monitoring. This medication should not be used in children under 12 years old or teenagers under 18 years old who have undergone tonsillectomy or adenoidectomy; administration should be avoided in adolescents between 12 and 18 years with specific risk factors. Symptoms of sleep apnea or hypoxemia may occur, so continuous monitoring of symptom worsening is essential, and dosage should be reduced or discontinued if necessary. This medication should not be used in patients with acute alcohol poisoning, central nervous system drug toxicity, severe respiratory depression, head injury, those taking MAO inhibitors, pregnant women, nursing mothers, or those with hypersensitivity to this medication or opioids. Patients with poor liver or kidney function, those who consume alcohol, a history of seizures, mental health issues, or a history of drug abuse should use it carefully and require thorough observation by a physician. Drowsiness or dizziness may occur while taking this medication, so patients should avoid driving or operating hazardous machinery. Moreover, prolonged use may lead to tolerance and reduced effectiveness, and sudden discontinuation may induce withdrawal symptoms, hence dosage should be gradually reduced. In the case of overdose, severe respiratory depression, seizures, or loss of consciousness may occur, requiring immediate emergency treatment, and naloxone may be used as an antidote. This medication should be stored out of reach of children and kept in its original container to prevent misuse or deterioration.

Side effects

  • spasms
  • hypersensitivity
  • shock
  • anaphylaxis
  • itching
  • hives
  • bronchospasm
  • angioedema
  • respiratory depression
  • dyspnea
Show 86 more
  • asthma exacerbation
  • hiccups
  • palpitations
  • coldness
  • mimicry concerns
  • vasodilation
  • hypotension
  • arrhythmia
  • facial pallor
  • syncope
  • orthostatic hypotension
  • tachycardia
  • bradycardia
  • hypertension
  • drowsiness
  • sleep
  • headache
  • heavy feeling in the head
  • excitement
  • tremors
  • tinnitus
  • tingling in both hands
  • anxiety
  • exhaustion
  • fatigue
  • lethargy
  • sweating
  • dizziness
  • unsteady gait
  • discomfort
  • difficulty urinating
  • dry mouth
  • thirst
  • confusion
  • impaired coordination
  • relief syndrome
  • restlessness
  • sleep disturbance
  • cognitive dysfunction
  • hallucinations
  • memory loss
  • attention deficit
  • depression
  • changes in appetite
  • sensory disturbances
  • epileptic seizures
  • involuntary muscle contractions
  • weakness
  • sleep apnea syndrome
  • hyperalgesia
  • nausea
  • vomiting
  • abdominal distension
  • abdominal discomfort
  • abdominal pain
  • loss of appetite
  • constipation
  • gastrointestinal irritation
  • hypertonia
  • muscle weakness
  • urinary retention
  • frequent urination
  • menopause syndrome
  • urination disorders
  • menstrual disorders
  • Stevens-Johnson syndrome
  • skin reactions
  • sweating
  • fever
  • feeling of heat
  • chills
  • feeling of cold
  • visual impairment
  • taste disorders
  • weight loss
  • injection site irritation
  • withdrawal symptoms
  • panic attacks
  • severe anxiety
  • sensory disturbances
  • pupil constriction
  • cardiovascular collapse
  • loss of consciousness
  • coma
  • spasms
  • dyspnea

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air exposure and keep it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White film-coated oblong extended-release tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.